- POSITIVE
Annual Revenue Metropolis Healthcare Mar-2026 Annual Revenue is Rs 1,382 Cr which is growth of 12.0% YoY.
- POSITIVE
Annual Net Profit Metropolis Healthcare Mar-2026 Annual Net Profit is Rs 157 Cr which is growth of 26.2% YoY.

Metropolis Healthcare Limited is a Mumbai based chain of diagnostic companies. It has 106 clinical laboratories 1130 collection centres in seven countries. In India, it has laboratories across 18 states and 173 cities for monitoring of disease, early detection, and diagnostic screening
| Bidding Dates |
|---|
| 03 Apr 2019 - 05 Apr 2019 |
| Subscription |
|---|
| 5.84x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹14,960 | 1 | 13 | 17 | 13.7 M | ₹877 - ₹880 | 72.73 % | ₹12,001.8 M - ₹12,042.9 M | RHP DOC |
Metropolis Healthcare IPO SUBSCRIPTION STATUS
05 Apr '19Metropolis Healthcare IPO overall subscription rate was 5.84 times the total available shares
Metropolis Healthcare IPO retail subscription rate was 2.21 times in the retail segment
Metropolis Healthcare IPO non-institutional investor subscription rate was 3.03 times in the non-institutional investor category
Metropolis Healthcare IPO Qualified Institutional Bidder subscription rate was 8.88 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 10% | 15% | 75% |
05 Apr 2019 | 2.21x | 3.03x | 8.88x |
Metropolis Healthcare FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from operations (Rs in millions) | Cash Flow from operations (Rs in millions) | Free Cash flow (Rs in millions) |
| 9MFY19 | 887.7 | 5,593.1 | 525.9 | 378.2 |
| FY18 | 1,097.5 | 6,435.7 | 1,039.3 | 899.6 |
| FY17 | 1,072.6 | 5,447.2 | 1,017.5 | 860.0 |
| FY16 | 819.6 | 4,754.7 | 914.2 | 810.2 |
Metropolis Healthcare IPO SUBSCRIPTION STATUS DETAILS
Metropolis Healthcare had 13.7 M shares on offer
Metropolis Healthcare IPO offer price was in the range ₹877 - ₹880
Metropolis Healthcare IPO minimum Investment was ₹14960
Metropolis Healthcare IPO issue size was ₹ 12,001.8 M - ₹ 12,042.9 M
Metropolis Healthcare had a minimum lot size of 17 Shares per application
Metropolis Healthcare NUMBER OF SHARES ON OFFER
Metropolis Healthcare IPO IMPORTANT DATES
| Issue Open Date | 03 Apr 2019 |
| Issue close Date | 05 Apr 2019 |
| Allotment Date | 10 Apr 2019 |
| Refund Date | 11 Apr 2019 |
| Demat Account Credit Date | 12 Apr 2019 |
| Listing Date | 15 Apr 2019 |
| Listing on Exchange(s) | NSE and BSE |
| Metropolis Healthcare Allotment Status | Exchange |
Metropolis Healthcare IPO subscription opened on 03 Apr 2019, and closed on 05 Apr 2019
IPO allotment for Metropolis Healthcare was finalized on Wednesday, 10 Apr 2019
IPO listing for Metropolis Healthcare was on NSE and BSE on Monday, 15 Apr 2019
Metropolis Healthcare IPO LISTING GAINS
| Issue Price (adjusted) | 220.0 |
| Listing Open Price | 960.0 |
| Listing Close Price | 959.5 |
| Listing Gain% | 9.1% |
| Current Gain% | 161.0% |
Metropolis Healthcare Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Metropolis Healthcare Ltd. | 574.2 | 2881 | 53.1 | 1.3 | 6.7 | 12.6 | 8.9 | 1671.4 | 24.1 | 190 | 31.1 | 10.8 | 41.8 |
| Dr. Lal Pathlabs Ltd. | 2000.7 | 33581.5 | 57.6 | 6.3 | 11.1 | 20.1 | 16 | 2864.2 | 12.1 | 504.8 | 3.6 | 34.8 | 9.2 |
| Inventurus Knowledge Solutions Ltd. | 1618.9 | 27776 | 34.7 | 1.1 | 6.7 | 25.8 | 16.9 | 3209.5 | 18.7 | 721.6 | 48.4 | 46.7 | 31.3 |
| Sagility Ltd. | 43.4 | 20317 | 19.8 | 0.7 | 2.5 | 9.6 | 7.3 | 7290.8 | 29.6 | 924.8 | 71.5 | 2.2 | 28.5 |
| Molbio Diagnostics Ltd. | 1486.4 | 17129.3 | 111 | 12 | 14.2 | 7.8 | 1455.2 | 41.6 | 166.6 | 14.8 | 13.4 | ||
| Indegene Ltd. | 662.4 | 15959.2 | 38.8 | -5 | 3.9 | 12.8 | 8.7 | 3582.5 | 21.6 | 401.1 | -1.4 | 17.1 | -7.8 |
Metropolis Healthcare annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Metropolis Healthcare INFORMATION ON IPO ISSUE
About Metropolis Healthcare
Metropolis Healthcare Limited is a Mumbai based chain of diagnostic companies. It has 106 clinical laboratories 1130 collection centres in seven countries. In India, it has laboratories across 18 states and 173 cities for monitoring of disease, early detection, and diagnostic screening
Object of the Issue
- Listing of the Equity Shares will enhance the visibility and brand image of company.
- Provide a public market for the Equity Shares in India.
Metropolis Healthcare - PROMOTERS
| Name |
|---|
| Ameera Sushil Shah |
| Metz Advisory LLP |
Metropolis Healthcare Book Running Lead Manager
JM Financial Limited
metropolis.ipo@jmfl.com
Credit Suisse Securities (India) Private Limited
list.metropolisipo@credit-suisse.com
Goldman Sachs (India) Securities Private Limited
gs-metropolis-ipo@gs.com
HDFC Bank Limited
metropolis.ipo@hdfcbank.com
Kotak Mahindra Capital Company Limited
metropolis.ipo@kotak.com
Metropolis Healthcare Registrar to the Offer
Link Intime India Private Limited
metropolis.ipo@kotak.com
Metropolis Healthcare Strengths
Leading diagnostics companies
It is of the leading diagnostics companies in India which is well positioned to leverage the expected growth in the Indian diagnostics industry
Widespread operational network
The company's operations are supported by a laboratory network comprising of 115clinical laboratories, including our GRL and a service network
Strong and established brand
Strong and established brand with a focus on quality and customer service
Metropolis Healthcare Risks
Legal proceedings
There are several outstanding legal proceedings against the Company, Subsidiaries, Directors andPromoters.
Incurred losses in the past
The Group Company has incurred losses in the financial years ending March 31, 2016, 2017 and 2018
IPO FAQs
Metropolis Healthcare Ltd. IPO listing opened at Rs 960.00 while the issue price was Rs 880.00 giving 9.09% returns. After adjusting for subsequent bonus and splits, the stock trades at Rs 220.00 giving 160.98% gains since its IPO listing.
This IPO consists of an offer for sale of up to Rs 1,204.3 crore, of 13,685,095 shares.
The promoters of the company are Ameera Sushil Shah and Metz Advisory LLP.
The category allocation of qualified institutional buyers is 75.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 10.0%.
The price band of the IPO is Rs 877.0 - 880.0.
The IPO application opens on Apr 03, 2019 and closes on Apr 05, 2019.
The minimum lot size for the IPO is 17. The maximum lot size for the IPO is 221.
For all category investors, the minimum application amount for this IPO is Rs. 14,960.0, the maximum value for this IPO is Rs 194,480.0.
This IPO will be allotted on Apr 10, 2019.
The refund will be credited to your account on Apr 11, 2019.
The allotted shares will be credited to your demat on Apr 12, 2019.
Metropolis Healthcare Ltd.’s shares listed on the stock exchanges on Apr 15, 2019.
